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The field of protein engineering has always attracted a
multidisciplinary cast of characters ranging from biologists
to organic chemists. Consequently, a variety of different
protein engineering techniques have been described which
encompass the purely synthetic and the purely biosyn-
thetic. Of these, heterologous expression of recombi-
nantly cloned genes is by far the most commonly employed
route to engineered proteins — in part because the approach
is readily accessible to most researchers. Although site-
directed mutagenesis is facilitated by the ‘replicative
fidelity and efficiency of living organisms’ [1], this of course
also constrains the approach to the naturally occurring
amino acids. This limitation is largely overcome by elegant
chemistry-driven approaches, such as unnatural amino acid
mutagenesis [2] and protein total or semi-synthesis via the
chemical [3–9] or enzymatic [10–13] ligation of unprotected
peptides. These approaches are, however, technically
demanding, a feature which has prevented their widespread
use by the biological community. Recently, a novel protein
semi-synthesis approach was reported [14–16] that har-
nesses the phenomenon of protein splicing (for review see
[17]), and in the process renders proteins harboring unnat-
ural building blocks accessible to most researchers. This
short review describes the genesis of this methodology,
termed ‘expressed protein ligation’ [14,15], its applications
thus far and its future potential in protein engineering.
The development of expressed protein ligation
Expressed protein ligation (EPL) allows synthetic pep-
tides to be chemically ligated to the C terminus of recom-
binant proteins through a normal peptide bond. The
approach arises from the unexpected convergence of two
areas of research which, at first glance, appear unrelated:
protein total synthesis [18] and protein self-splicing [17].
The total chemical synthesis of proteins has in recent
years been dominated by the use of powerful fragment
condensation approaches that allow fully unprotected
peptide building blocks to be regioselectively pieced
together in aqueous solution [19]. Unlike full-length pro-
teins, peptide fragments can be efficiently assembled by
stepwise solid-phase peptide synthesis (synthetic poly-
peptides of up to ~50 residues are now readily accessible
[20]). Moreover, by using unprotected peptides these
modern ligation approaches overcome the solubility and
characterization problems associated with classical con-
vergent synthesis (reviewed in [21]). 
Among the various chemical and enzymatic ligation
methods in use, so-called ‘native chemical ligation’ [22]
has proven the most general route to fully synthetic pro-
teins [22–27]. As illustrated in Figure 1a, native chemical
ligation relies on the highly efficient reaction that occurs
between a peptide possessing an N-terminal cysteine residue
(peptide 2; Figure 1a) and a second peptide possessing
an αthioester moiety (peptide 1; Figure 1a). Following an
initial intermolecular, and important chemoselective reac-
tion, the resulting thioester-linked intermediate sponta-
neously rearranges via an S→N acyl transfer to give the
final amide-linked product. As was pointed out in the
initial description of the technique [22], the C-terminal
segment could be expressed using recombinant DNA
methods; provided the polypeptide contained an N-termi-
nal cysteine, it could be used in native chemical ligation.
Indeed, this semi-synthetic version of native chemical lig-
ation has been successfully used to attach an ethylene-
diamine-tetraacetic acid (EDTA) analog to the N termi-
nus of a chimeric heterodimer of the transcription factors
c-Jun and c-Fos [28]. 
Although biotechnology provides the necessary tools
required to generate N-terminal cysteine-containing pro-
teins, the same has not been true for the production of
recombinant protein αthioesters. Thus, native chemical
ligation could not be fully interfaced with recombinant
protein biotechnology. It is at this point that we must
introduce protein splicing into our story, as this phenome-
non provides the final piece of the puzzle. Protein splic-
ing, first detected in yeast nearly a decade ago [29], is a
post-translational event in which a proprotein undergoes
an intramolecular rearrangement resulting in the extrusion
of an internal sequence (termed an intein [30]) and the
concomitant joining together of the flanking sequences
(exteins) to form an edited version of the original protein.
Unlike RNA splicing, which requires the help of an elabo-
rate ribonuclear protein complex, protein splicing is an
intrinsic process and can take place in vitro using purified
proproteins [31]. This has allowed the mechanism of the
process to be studied in some detail using both mutagene-
sis and protein chemistry based techniques [31–33]. 
Our current understanding of the mechanism of protein
splicing is summarized in Figure 1b. The first step involves
an N→S or N→O acyl shift in which the N-extein is
transferred to the sidechain sulfhydryl/hydroxyl group of
the first residue in the intein — a cysteine, serine or
threonine residue is always located at this position. This
rearrangement would appear to be energetically unfavor-
able and is essentially the reverse of the final step in
native chemical ligation (Figure 1a). Although the driving
force(s) behind this event is (are) still the subject of study,
it is interesting to note that in the recently solved crystal
structure of the GyrA intein, the amide bond formed
between the final residue in the N-extein and the first
residue in the intein is observed to be in the higher energy
cis conformation [34]. It is possible that this unusual
stereochemical constraint helps push the equilibrium of
the system towards the ester/thioester side. Given that all
inteins are likely to share a common fold, it is intriguing to
speculate that this type of stereochemical ‘leg-up’ may be
a general feature of protein splicing. 
After the initial N→(S/O) rearrangement there follows a
trans esterification step in which the N-extein is trans-
ferred to the sidechain of a second conserved cysteine,
serine or threonine residue, this time located at the
intein–C-extein junction. In the next step, the amide
bond at the intein–C-extein junction is broken as a result
of succinimide formation involving the conserved C-ter-
minal asparagine residue within the intein. In the final
step of the process, a peptide bond is formed between the
N-extein and C-extein following an (S/O)→N acyl shift —
identical to the final step in native chemical ligation. 
The uncanny chemical similarities between native chemi-
cal ligation (Figure 1a) and protein splicing (Figure 1b)
raises an interesting question: is it possible to use protein
splicing as a route to the formation of recombinant protein
αthioesters for use in native chemical ligation? This
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Figure 1
Native chemical ligation and protein splicing provide the basis for a new protein semi-synthesis method. The three different techniques discussed
in the text are illustrated: (a) native chemical ligation, (b) protein splicing and (c) expressed protein ligation.
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question is further highlighted following the recent clever
demonstration by Xu and coworkers that protein splicing
can be halted in midstream (presumably at the thioester
/ester intermediate stage) by mutation of the key aspara-
gine residue in the intein to an alanine residue [35].
Indeed, an engineered intein of this type now forms the
basis of a commercially available protein expression/purifi-
cation strategy (New England Biolabs). 
Now with all the pieces in place, recent months have seen
the publication of a series of papers [14–16] that pull
together protein splicing and native chemical ligation into
a general new protein semi-synthesis approach. The prin-
ciple of the method, referred to as expressed protein liga-
tion (EPL) [14,15], is shown in Figure 1c. In the first step,
the protein or protein fragment of interest is expressed as
an intein–CBD (chitin binding domain) fusion protein,
where the CBD allows the protein of interest to be affinity
purified using chitin beads. Because an engineered intein
is being used, protein splicing is unable to proceed to
completion and is thus stalled at the stage involving the
thioester-linked intermediate. Consequently, exposure of
the immobilized fusion protein to an aqueous solution
containing of an N-terminal cysteine-peptide and a thiol
reagent (e.g. thiophenol) results in native chemical liga-
tion of the peptide to the protein. The nature of the thiol
agent used is of key importance to this process as it dic-
tates the reactivity of the protein αthioester generated in
situ during the reaction. Thus, thiophenol is a good choice
as phenyl αthioesters are known to be extremely reactive
in native chemical ligations [25].
Although the three reports to date all use more or less
the same procedure shown in Figure 1c, they each illus-
trate a different potential application of EPL. The first
study makes use of the commercially available Saccharo-
myces cerevisiae (Sce) VMA intein (Asn454→Ala) and
demonstrates the utility of the approach for site-specific
modification of recombinant proteins [14]. EPL was used
to test the hypothesis that addition of a phosphotyrosine
tail to the C terminus of the protein tyrosine kinase Csk
(C-terminal Src kinase) would, as in the Src family
members [36,37], result in an intramolecular association
between the phosphotyrosine and the Src homology 2
(SH2) domain within the protein. Because Csk is not nat-
urally tyrosine phosphorylated at this position and con-
tains 20 tyrosine residues within its sequence, the
desired 450 amino acid phosphoprotein could not be
generated using standard biotechnology techniques.
Thus, EPL was used to ligate a short phosphotyrosyl-
peptide to the C terminus of Csk, the reaction proceed-
ing in essentially quantitative yield. Biochemical analysis
of the semi-synthetic tail-phosphorylated Csk construct
indicated the presence of an intramolecular phosho-
tyrosine–SH2 interaction. Interestingly, the Csk contain-
ing the phosphorylated tail appears to have increased
kinase activity towards the physiologically relevant
substrate, Lck, compared with the nonphosphorylated
version of the protein [14].
A second application of EPL, also using the commercially
available Sce VMA intein, illustrates how the technique
could prove extremely useful in studying complex bio-
chemical machines. In this study, a fully functional semi-
synthetic version of Escherichia coli RNA polymerase was
prepared [15]. EPL was used to ligate a synthetic peptide
corresponding to residues 568–600 of the σ70 specificity
factor to a recombinant fragment corresponding to the
remainder of the σ70 protein (residues 1–566). The result-
ing ~600 amino acid construct was shown to be fully active
in initiating transcription when added to the other sub-
units of E. coli RNA polymerase, and was used to map the
binding region of the bacteriophage T4 antisigma protein
(AsiA) to the C-terminal region of the σ70 subunit. The
ability to introduce biochemical or biophysical probes into
large multiprotein complexes, such as RNA polymerase,
in a site-specific manner may provide new ways to study
the structure and function of these complex biochemical
machines. Along these lines, recent studies from our labo-
ratory indicate that EPL can be used to introduce fluores-
cent probes into the preassembled ~500 kDa E. coli RNA
polymerase complex in a site- and subunit-specific manner
(TWM et al., unpublished data).
In a third application, EPL has been used to prepare
fully active semi-synthetic versions of bovine pancreatic
ribonuclease (RNase A) and the restriction endonucle-
ase, Hpa I, from Haemophilus parainfluenzae [16]. Both of
these proteins are potentially cytotoxic to bacteria when
expressed in their full-length forms, making their over-
expression inefficient. The use of EPL, however, allowed
inactive N-terminal fragments of the proteins to be
safely expressed and then ligated in vitro to short syn-
thetic peptides corresponding to the remainder of the
proteins. Following refolding, the full-length semi-syn-
thetic proteins were shown to have enzymatic properties
indistinguishable from their natural counterparts. Inter-
estingly, these semi-synthetic proteins were prepared
using a slightly modified version of EPL as compared to
the studies described above: a genetically engineered
Mycobacterium xenopi (Mxe) GyrA intein was used rather
than an Sce VMA intein, and 2-mercaptoethanesulfonic
acid was used rather than thiophenol. Use of this intein/
thiol combination was found to give higher yields of
semi-synthetic product for these two examples. This
suggests, as the authors point out, that for some targets
more than one intein system may have to be tried to
obtain optimal ligation results.
Protein splicing in trans
The recent observation that protein splicing can be trig-
gered in vitro by simply reconstituting inactive N- and
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C-terminal fragments of an intein [38–41], adds an extra
dimension to the use of splicing in protein engineering.
So-called trans-splicing is made possible because of the
modular composition of the intein element; of the ~40
inteins identified to date all but two (the Porphra pur-
purea DNaB intein [42] and the Mxe GyrA intein [43])
contain a homing endonuclease protein module sand-
wiched between the functionally important flanking
regions of the intein. Indeed, mutagenesis and sequence
alignment studies have shown that this entire endo-
nuclease domain can be deleted from the intein without
destroying splicing activity in the resulting minimal
inteins [40,43]. This finding suggested that it might be
possible to obtain a folded, functional intein from two
noncovalently associated intein fragments. This has in
fact been shown to be the case in two systems: the Psp
Pol-1 intein [38] and the Mycobacterium tuberculosis RecA
intein [39,40]. In the process of trans-splicing, the two
proteins to be joined are expressed as constructs with
one of a pair of complementary intein fragments. Bringing
these two proteins together in vitro under suitable condi-
tions results in splicing (see Figure 2).
As illustrated in Figure 2, the real attraction of trans-splicing
from a protein engineering point of view, is that it allows
recombinant proteins from two different sources to be
ligated together in vitro. As with EPL, this feature may
prove to be extremely useful for obtaining cytotoxic pro-
teins impossible to generate using standard approaches. An
additional use of trans-splicing was recently reported by
Yamazaki and coworkers who used fragments of the Pyro-
coccus furiosus PI-PfuI intein to link together two domains of
the α subunit of E. coli RNA polymerase [41]. This system
allowed the group to express one half of the α subunit in
15N labeled media and the other in standard media. Conse-
quently, the product obtained after ligation was partially
labeled with 15N allowing this domain to be selectively
detected using heteronuclear two-dimensional nuclear
magnetic resonance (2D NMR) experiments. As demon-
strated by this work, trans-splicing may have enormous
954 Structure 1998, Vol 6 No 8
Figure 2
Protein splicing in trans. This in vitro strategy
can be used to chemically ligate two
recombinant polypeptide chains which have
been expressed and purified separately. The
two recombinant proteins to be linked
together, represented in red and yellow, are
each fused to a nonfunctional segment of an
intein. When reconstituted in vitro, the two
intein segments noncovalently associate to
give a folded intein capable of supporting
protein splicing (as outlined in Figure 1b).
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implications for the study of large multidomain proteins by
high-field NMR spectroscopy.
Future outlook
One of the most important features of EPL and (poten-
tially) trans-splicing is that they are technically easy to
perform, a basic knowledge in recombinant protein expres-
sion is really all that is required. Moreover, in the case of
EPL the necessary expression vector is commercially
available and customized peptides containing N-terminal
cysteine residues can be obtained from a variety of
sources. How then can these approaches be used to com-
plement the type of information already available through
standard biotechnology techniques? In the case of EPL,
the ability to incorporate biochemical probes (e.g. cross-
linkers), biophysical probes (e.g. fluorophores and spin
labels) and post-translational modifications (e.g. phospho-
rylated and glycosylated residues) into large proteins and
protein complexes in a site-specific manner will doubtless
be of enormous value in the study of these systems.
Equally, the ability to obtain cytotoxic proteins either by
EPL or trans-splicing will allow such proteins to be gener-
ated in sufficient quantities for rigorous structural and
functional studies. Segmental isotope labeling, which has
also been successfully performed by EPL of labeled and
unlabeled recombinant proteins (TWM et al., unpublished
data), represents an exciting application of these technolo-
gies in the field of structural biology.
As pointed out earlier in this article, methods already
exist for the generation of recombinant proteins contain-
ing an N-terminal cysteine residue. With the advent of
EPL, native chemical ligation reactions can now be per-
formed at either end of a recombinant protein. This of
course allows two recombinant proteins to be directly
ligated together (similar to trans-splicing), but it also
opens the way for the insertion of synthetic peptides into
recombinant proteins. The most obvious way to achieve
this is to adapt the sequential native chemical ligation
strategies already in use for the directed assembly of
three or more synthetic peptides [27,44]. The implica-
tion of being able to specifically insert small synthetic
peptide cassettes into large proteins is that the entire
primary structure is made amenable to modification, and
not merely the extreme N- or C-terminal regions. It is
also worth noting that introduction of both an N-terminal
cysteine and a C-terminal thioester within the same
polypeptide chain allows intramolecular native chemical
ligation reactions to be performed [45,46], a process which
has been used to prepare a synthetic circular protein
domain [47]. It is easy to conceive how head-to-tail
cyclized recombinant peptides and proteins could be
obtained in an analogous manner using EPL.
This review began with the statement that protein engi-
neering is a multidisciplinary endeavor, requiring the
interactions of many scientific fields. The novel tech-
nique of EPL continues in that tradition, combining
chemistry and biology to pave new roads towards chemi-
cally engineered macromolecules.
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